ArticleTranslational cancer research2025

Emodin reverses sorafenib resistance in hepatocellular carcinoma by inhibiting epithelial-mesenchymal transition via the Akt signaling pathway.

Qingqing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.